4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine manufacturers
|
| | 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Basic information |
| Product Name: | 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine | | Synonyms: | 4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine;Tofacitinib impurity 21/4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine;Tofacitinib-27;4,7'-Bi-7H-pyrrolo[2,3-d]pyrimidine, 4'-chloro-;Azilsartan medoxomil impurity330;Tofacitinib Related Compound 29Q: What is
Tofacitinib Related Compound 29 Q: What is the CAS Number of
Tofacitinib Related Compound 29;4-chloro-7-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-7H-pyrrolo[2,3-d]pyrimidine;4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine(Tofacitinib impurity ) | | CAS: | 134965-85-8 | | MF: | C12H7ClN6 | | MW: | 270.68 | | EINECS: | | | Product Categories: | | | Mol File: | 134965-85-8.mol | ![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Structure](CAS/20200611/GIF/134965-85-8.gif) |
| | 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Chemical Properties |
| Boiling point | 397.4±52.0 °C(Predicted) | | density | 1.74±0.1 g/cm3(Predicted) | | pka | 10.39±0.20(Predicted) |
| | 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Usage And Synthesis |
| | 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine Preparation Products And Raw materials |
|